ALI

American Life, Inc. Reaches a Monumental Milestone with over 8,000+ Visa Application Sponsorships

Retrieved on: 
Wednesday, April 3, 2024
ALI, Partnership, Risk, EB-5, Visa, Investment, Financial services

American Life, Inc. is a premier EB5 capital funding company helping eligible immigrant investors obtain a lawful permanent residence in the US. The company recently passed a significant milestone by sponsoring more than 8,000+ visa applications.

Key Points: 
  • According to ALI's CEO Henry Liebman, American Life, Inc. recently celebrated a historic moment in the company's operation by sponsoring more than 8,000 Visa applications, stating:
    Henry underscored that American Life, Inc .
  • This all-encompassing strategy is the key to ALI being able to successfully sponsor more than 8,000 Visa applications.
  • At the end of the partnership, American Life, Inc. returns the original principal balance through a liquidity event.
  • More information about American Life, Inc. is available on the company's official website .

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

Retrieved on: 
Tuesday, March 12, 2024
Abstract, Chlorine, Survival, SOT, University, Doctor of Philosophy, MD, Code, FAHA, Society, Translation, Safety, Tokyo Stock Exchange, ALI, Edema

In this study, single-dose and multi-dose treatments were evaluated.

Key Points: 
  • In this study, single-dose and multi-dose treatments were evaluated.
  • The primary endpoint was the mean change in the pulmonary function measure PaO2/FiO2, which is the ratio of arterial oxygen partial pressure to fractional inspired oxygen.
  • Additional endpoints included survival, lung mechanics, lung injury, and edema formation evaluated by chest x-ray.
  • Cl2 gas concentration of 210 ppm x 30 min was expected to result in a 20 - 30% mortality rate (Fukuda 2015).

Almonty Industries Inc. - Placement of Common Share Units and CDI’s raises C$1.47 million1 with Further Commitments of C$1.178 million for acceleration of Tungsten downstream planning and Molybdenum reserves conversion.

Retrieved on: 
Saturday, March 23, 2024
Finance, Natural Resources, Professional Services, Other Natural Resources, Mining, Minerals, Indian stock exchange, Private placement, ANY, Private, CDI, APT, Minority, Risk, ASX, Sale, Acquisition, Placement, Lead, THIS, Tungsten, Moly, TSX, AII, ALI, Multilateral, UPDATE, Person

Proceeds from the Placement will be applied towards general working capital, including accelerating the downstream project planning and further investigation of the Moly due to increasing interest in the material domestically.

Key Points: 
  • Proceeds from the Placement will be applied towards general working capital, including accelerating the downstream project planning and further investigation of the Moly due to increasing interest in the material domestically.
  • The Placement Units and Placement CDI’s issued will rank equally with existing CDI’s and Common Shares on issue.
  • The closing of the CDI Placement is subject to receipt of all necessary regulatory approvals, including the acceptance by the TSX and ASX.
  • READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD- LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE.

The American College of Trust and Estate Counsel (ACTEC) Announces Susan D. Snyder as New President

Retrieved on: 
Wednesday, March 20, 2024
College, Continuing legal education, Chicago Bar Association, Audit, Trust, American Bankers Association, Great Lakes region, Executive Committee, Financial management, Founding, American College, Estate planning, ALI, Region, State, Drug

WASHINGTON, March 20, 2024 /PRNewswire-PRWeb/ -- The American College of Trust and Estate Counsel (ACTEC) today announced that Susan D. Snyder will serve as the 2024–2025 President. Snyder is a Senior Planner on Northern Trust's Regional Wealth Advisor Team in Chicago, Illinois. She succeeds 2023–2024 ACTEC President Kurt A. Sommer of Sommer Udall Law Firm, P.A., in Santa Fe, New Mexico.

Key Points: 
  • The American College of Trust and Estate Counsel (ACTEC) today announced that Susan D. Snyder will serve as the 2024–2025 President.
  • She succeeds 2023–2024 ACTEC President Kurt A. Sommer of Sommer Udall Law Firm, P.A., in Santa Fe, New Mexico.
  • WASHINGTON, March 20, 2024 /PRNewswire-PRWeb/ -- The American College of Trust and Estate Counsel (ACTEC) today announced that Susan D. Snyder will serve as the 2024–2025 President.
  • "I look forward to guiding ACTEC in our shared mission of advancing the standards of trust and estate law practice," said Snyder.

March is National Ladder Safety Month: Help is Available for Home DIYers

Retrieved on: 
Friday, March 1, 2024
Men, Landscape, Public Policy, Government, Interior Design, Home Goods, Architecture, Consumer, Other Construction & Property, Residential Building & Real Estate, Construction & Property, Public Safety, Other Education, Retail, Education, Other Consumer, Women, Seniors, ALI, Heart, Work, NOT, Workplace, Multimedia

Taking the time to become familiar with basic ladder safety is something every homeowner should do, and is encouraged by the American Ladder Institute (ALI), the founder of National Ladder Safety Month.

Key Points: 
  • Taking the time to become familiar with basic ladder safety is something every homeowner should do, and is encouraged by the American Ladder Institute (ALI), the founder of National Ladder Safety Month.
  • View the full release here: https://www.businesswire.com/news/home/20240301826747/en/
    March is National Ladder Safety Month: Help is Available for Home DIYers.
  • National Ladder Safety Month 2024 will focus on four key themes, one each week.
  • Take the goals of National Ladder Safety Month to heart, use the available resources, and approach the next home project with confidence.

Werner Tips Off Ladder Safety Month a Day Early

Retrieved on: 
Thursday, February 29, 2024
ALI, CST, Leap Day, JSS, Safety, Security, Construction

ITASCA, Ill., Mar. 0, 2024 /PRNewswire/ -- Werner, the World leader in ladders and the Official Ladder of NCAA® March Madness®, tipped off Ladder Safety Month this morning with ladder safety training events across the country. Recognizing 2024 as a leap year, the Jobsite Safety and Security (JSS) team identified the opportunity to add an extra day to spread the word about ladder safety.

Key Points: 
  • 0, 2024 /PRNewswire/ -- Werner, the World leader in ladders and the Official Ladder of NCAA® March Madness®, tipped off Ladder Safety Month this morning with ladder safety training events across the country.
  • Recognizing 2024 as a leap year, the Jobsite Safety and Security (JSS) team identified the opportunity to add an extra day to spread the word about ladder safety.
  • "Our jobsite safety teams are doing onsite safety training all across the country almost every day," said Chad Lingerfelt, Director of Safety Training at WernerCo.
  • In addition to this one-day training blitz, Werner is supporting American Ladder Institute's (ALI) Ladder Safety Month initiative for the 8th straight year.

Automated Teller Machine Market size to grow by USD 5.64 billion from 2022 to 2027; Multifunctionality features of ATMs boosts the market growth - Technavio

Retrieved on: 
Tuesday, February 6, 2024
ATM, Growth, Fortune teller machine, NCR Corporation, POS, USD, Fujitsu, Diebold Nixdorf, Geography, Automation, MPS, ALI, Hitachi, Triton Systems, Music

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The automated teller machine market is estimated to grow by USD 5.64 billion from 2022 to 2027, growing at a CAGR of 4.56%.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The automated teller machine market is estimated to grow by USD 5.64 billion from 2022 to 2027, growing at a CAGR of 4.56%.
  • The automated teller machine market is fragmented owing to the presence of many global and regional companies.
  • The managed print services (MPS) market size is forecast to increase by USD 7.67 billion, at a CAGR of 4.9% between 2023 and 2028.
  • The personal travel accident insurance market size is forecast to increase by USD 37.6 billion, at a CAGR of 6.66% between 2023 and 2028.

Ladder Safety Begins at Home

Retrieved on: 
Tuesday, January 30, 2024
Other Consumer, Women, Men, Specialty, Home Goods, Family, Training, Consumer, Retail, Education, Injury, Accident, ALI, Safety, DIY, WETV, Construction

One of the latest is a ladder safety video featuring Jennifer Bonner, host of “The Lifestyle List” on WeTV.

Key Points: 
  • One of the latest is a ladder safety video featuring Jennifer Bonner, host of “The Lifestyle List” on WeTV.
  • In the three-minute video, Bonner demonstrates basic ladder safety tips and directs viewers to the many resources ALI has available to aid in safe ladder usage.
  • These resources include ALI’s dedicated ladder safety training site, with a name that’s easy to remember: https://www.laddersafetytraining.org/ .
  • Ladder-users can also visit the Ladder Safety Month website ( https://www.laddersafetymonth.com/Safety-Resources/Flyers ) and ALI’s main website ( https://www.americanladderinstitute.org/ ) for a host of ways to get trained on better ladder safety practices.

Almonty Announces the Filing of Its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Nine Months Ended September 30, 2023 and $1.74M in Positive EBITDA From Mining Operations(1)

Retrieved on: 
Tuesday, November 14, 2023
Mining, Minerals, Natural Resources, AII, Bank statement, TSX, ALI, News, Cryptocurrency

Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) today announced the filing of its unaudited interim condensed consolidated financial statements and management’s discussion & analysis (“MD&A”) for the three and nine months ended September 30, 2023.

Key Points: 
  • Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) today announced the filing of its unaudited interim condensed consolidated financial statements and management’s discussion & analysis (“MD&A”) for the three and nine months ended September 30, 2023.
  • Unless otherwise indicated, all currency amounts contained in this news release are expressed in Canadian dollars.
  • The following financial information is for the three and nine months ended September 30, 2023 and 2022:

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)

Retrieved on: 
Tuesday, November 14, 2023
ICH, Rivaroxaban, Buerger's test, Research, Safety, Johnson & Johnson, Thrombin, Food, PAD, DPI, American Heart Association, AHA, Risk, Amputation, CAD, Patient, ALI, Myocardial infarction, Intracerebral hemorrhage, Coagulation, LER, TIMI, FDA, Medical Affairs Bureau, Division, Janssen Pharmaceuticals, Comorbidity, MACE, Vascular disease, Stroke, Standard of care, University, Bleeding, Aspirin, EGFR, Janssen, Disability, Anschutz Medical Campus, Metabolism, Pharmaceutical industry

TITUSVILLE, N.J., Nov. 14, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO® (rivaroxaban [2.5 mg twice daily plus aspirin 100 mg once daily]) over standard of care (aspirin alone). Data from the two analyses demonstrate the role of XARELTO® in treating both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD). Results were presented at the American Heart Association's (AHA) 2023 Scientific Sessions, hosted in Philadelphia, Pennsylvania, November 11-13, 2023.

Key Points: 
  • "These analyses reinforce the consistency of the favorable benefit-risk profile of XARELTO® plus aspirin for patients with vascular disease, regardless of comorbidity.
  • In fragile patients treated with XARELTO® plus aspirin, 6.2% of patients experienced a MALE compared to 10.3% of patients treated with placebo.
  • In patients with PAD only, 11% of patients treated with XARELTO® plus aspirin experienced a MACE versus 9.8% of patients treated with placebo.
  • Overall, the safety of XARELTO® plus aspirin in patients with PAD was consistent regardless of CAD with no significant interactions.